US Corporate Distress Financial Stress SEC Filings — May 07, 2026

07-05-2026

ProPetro Holding Corp. (NYSE: PUMP) priced an upsized $600 million aggregate principal amount of 0.00% convertible senior notes due 2031, increased from the previously announced $500 million, with settlement scheduled for May 7, 2026. Net proceeds are estimated at $581.3 million (or $668.6 million if the $90 million option is fully exercised), to be used for $32.0 million in capped call transactions and general corporate purposes including growth capital for power generation equipment. The notes are senior unsecured obligations with an initial conversion price of $23.17 per share, a 37.5% premium over the May 4, 2026 closing price of $16.85.

• ·Initial conversion rate: 43.1616 shares of common stock per $1,000 principal amount of notes.
• ·Notes mature on November 15, 2031; convertible from August 15, 2031, or earlier upon certain events.
• ·Capped call cap price initially $29.49 per share.
• ·Notes redeemable on or after May 15, 2029, if stock price exceeds 130% of conversion price.
• ·Fundamental change allows noteholders to require repurchase for cash.

07-05-2026

Booking Holdings Inc. executed an Officers’ Certificate on May 7, 2026, for the issuance of $750,000,000 aggregate principal amount of 5.375% Senior Notes due 2036, following an underwriting agreement dated May 5, 2026, with Citigroup Global Markets Inc., Deutsche Bank Securities Inc., Goldman Sachs & Co. LLC, and J.P. Morgan Securities LLC as representatives. The Senior Notes are general senior unsecured obligations, bearing semi-annual interest at 5.375% starting November 7, 2026, and maturing on May 7, 2036, unless redeemed earlier. No period-over-period financial metrics are provided in the filing.

• ·Senior Notes are redeemable prior to February 7, 2036 (Par Call Date) at the greater of 100% of principal or present value of remaining payments discounted at Treasury Rate plus 15 basis points, plus accrued interest.
• ·Indenture includes customary events of default, with acceleration possible by Trustee or holders of 25% of outstanding principal upon non-bankruptcy defaults.
• ·Offering conducted pursuant to shelf Registration Statement (File No. 333-273678).

07-05-2026

Cross Country Healthcare, Inc. (NASDAQ: CCRN) has entered a definitive agreement to be acquired by Knox Lane for $13.25 per share in an all-cash transaction valued at $437 million, a 31% premium to the May 6, 2026 closing price and 45% premium to the 90-day volume-weighted average trading price. The transaction is expected to close in Q3 2026, subject to stockholder approval and regulatory clearances, after which the company will become privately held and cease trading on Nasdaq. No operating performance metrics were provided, but executives highlighted the strategic fit and growth potential under Knox Lane's ownership.

• ·Advisors: BofA Securities, Inc. (financial) and Davis Polk & Wardwell LLP (legal) for Cross Country; MTS Health Partners (financial) and Kirkland & Ellis LLP (legal) for Knox Lane.
• ·Company will continue operating under the Cross Country Healthcare name and brand post-transaction.
• ·Definitive proxy statement to be filed with SEC; stockholders urged to read for details.

07-05-2026

Avalo Therapeutics entered into an underwriting agreement on May 5, 2026, to issue and sell 19,730,000 shares of common stock at $17.75 per share and 1,400,000 pre-funded warrants at $17.749 each, with the underwriters fully exercising their option for an additional 3,169,500 shares, expecting net proceeds of approximately $405.0 million. As of March 31, 2026, the company had preliminary cash, cash equivalents, and short-term investments of $82.0 million, and together with the offering proceeds, expects to fund operations into 2029, primarily for advancing abdakibart through Phase 3 topline data release. The offering is expected to close on May 7, 2026, subject to customary conditions.

• ·Pre-Funded Warrants exercisable at $0.001 per share or via cashless exercise, with ownership limit initially set at 4.99% or 9.99%, adjustable up to 19.99% upon 61 days' notice.
• ·Underwriting option exercisable for 30 days after Prospectus Supplement dated May 5, 2026.
• ·Prospectus Supplement filed with SEC on May 6, 2026, under Form S-3 effective January 20, 2026.

07-05-2026

Faraday Future announced plans to upgrade the FX Super One MPV to a more competitive 800V BEV or accelerate the AIHER hybrid project, pausing the original 400V cooperation and potentially delaying mass-production deliveries until strategic financing is secured. The company has shipped 68 EAI robots as of April 30, 2026, achieving positive gross margins, with May shipments accelerating toward a first-quarter target of 200 units and cumulative 2026 shipments exceeding 1,000 units, supported by $45M in recent financing. This strategic shift prioritizes robotics ramp-up to reduce near-term cash outflows and financial risk, but underscores dependency on future funding and execution challenges.

• ·Super One 800V BEV delivery timeline post-funding: first phase 6-9 months, second 12-15 months, third 21-24 months
• ·AIHER hybrid delivery timeline post-funding: first phase 9-12 months, second 21-24 months, third 24-28 months
• ·Press release dated May 5, 2026; SEC filing May 7, 2026

07-05-2026

Americold Realty Trust filed an 8-K on May 7, 2026 (AccNo: 0001193125-26-210231), reporting under Item 1.01 entry into a material definitive agreement, Item 7.01 Regulation FD disclosure, and Item 9.01 financial statements and exhibits. This is a multi-item filing with no specific transaction details, financial metrics, dollar values, or impacts disclosed. No positive or negative metrics, comparisons, or guidance changes are mentioned.

07-05-2026

On May 4, 2026, the Board of Directors of Nakamoto Inc. approved a revised form of director and officer indemnification agreement and entered into such agreements with each current director and officer, superseding the previous form. The agreements enhance indemnification rights and expense advancement to the fullest extent permitted by Delaware law, subject to limitations for fraud or willful misconduct, and include provisions for insurance maintenance and independent counsel post-change in control. No financial terms or compensation amounts were disclosed.

• ·Agreements filed as Exhibit 10.1.
• ·Securities: Common Stock (NAKA) on Nasdaq; Tradeable Warrants (NAKAW) on OTC Pink.

07-05-2026

Resolute Holdings reported Q1 2026 GAAP net income attributable to common stockholders of $61.5M ($7.19 diluted EPS) versus a $3.4M loss ($0.39 loss per share) YoY, and Non-GAAP Fee-Related Earnings of $5.9M ($0.69 per share) versus a $0.6M loss ($0.07 loss per share), driven by management fees rising to $12.9M from $1.1M due to the new Husky Holdings agreement and CompoSecure growth. However, consolidated results showed an operating loss of $5.8M versus $25.6M income, with net sales at $407.8M but weighed down by SG&A expenses of $162.6M (up from $28.9M), interest expense $30.1M (from $3.5M), and a $106.8M loss on debt extinguishment, leading to operating cash use of $116.8M versus $18.4M provided. The company repurchased $38.0M in common shares amid balance sheet expansion from GPGI Holdings consolidation.

• ·Consolidated balance sheet total assets increased to $6,215.0M from $333.4M due to GPGI Holdings consolidation.
• ·Long-term debt increased to $2,178.3M from $169.8M.
• ·Cash and cash equivalents decreased to $113.1M from $161.4M QoQ.
• ·Equity-based compensation expense $2.3M in Q1 2026 vs $6.0M YoY.

07-05-2026

Angelini Pharma S.p.A. has agreed to acquire Catalyst Pharmaceuticals, Inc. (CPRX) for $31.50 per share in cash, totaling approximately $4.1 billion USD (equivalent to 3.5 billion euros), representing premiums of 21% to the unaffected closing price and 28% to the 30-day VWAP as of April 22, 2026. The transaction, unanimously approved by both boards, is expected to close in Q3 2026 subject to stockholder approval, regulatory clearances, and customary conditions, marking Angelini Pharma's U.S. market entry. Separately, Catalyst resolved all pending FIRDAPSE patent litigation with Hetero USA, Inc. and affiliates via a settlement agreement.

• ·Acquisition financed with cash and debt; no financing condition.
• ·Catalyst to become wholly owned subsidiary of Angelini Pharma post-merger.
• ·Financial advisors: Centerview Partners (lead for Angelini), J.P. Morgan (sole for Catalyst).
• ·Catalyst's 2026 annual stockholder meeting suspended due to transaction.
• ·Settlement with Hetero terminates all FIRDAPSE patent litigation; to be submitted to FTC and DOJ.

07-05-2026

Alaska Silver Corp. approved amendments to its articles on May 7, 2026, to simplify its capital structure by eliminating the unissued proportionate voting shares (PV Shares) class, reidentifying subordinate voting shares (SV Shares) as common shares, and authorizing an unlimited number of common shares with no par value or special rights. This follows a 2025 name change from Western Alaska Minerals Corp. and a 2023 shareholder ratification creating the dual-class SV and PV structure. No PV Shares are currently issued or outstanding, so the alteration has no immediate impact on existing shareholders.

• ·Resolution passed by directors on May 6, 2026; effective May 7, 2026 upon filing with BC Registrar.
• ·Prior name change resolution on April 2, 2025; effective April 25, 2025.
• ·Dual-class structure ratified by shareholders on July 17, 2023; effective August 10, 2023.
• ·Deletes Part 23 of Articles in its entirety.
• ·SV Shares convertible to PV Shares at 100:1 ratio under certain takeover offers.

07-05-2026

Kala Bio, Inc. adopted a Certificate of Amendment to its Restated Certificate of Incorporation, approved by the Board of Directors and stockholders, implementing a 1-for-50 reverse stock split effective at 4:05 p.m. New York time on May 8, 2026. Under the reverse split, every 50 shares of old common stock ($0.001 par value) are reclassified into one share of new common stock, with no fractional shares issued and cash payments provided in lieu thereof based on the Nasdaq Capital Market closing price on May 7, 2026. This structural change aims to consolidate shares without altering overall stockholder equity proportions.

• ·Original Certificate of Incorporation filed July 7, 2009
• ·Par value of common stock: $0.001 per share

07-05-2026

On May 1, 2026, Polar Power, Inc. received a Nasdaq letter stating non-compliance with Listing Rule 5550(b)(1) due to stockholders’ equity of only $144,000 as of December 31, 2025, far below the required $2.5 million minimum. The company has 45 days to submit a compliance plan and, if accepted, 180 days to regain compliance, with no immediate impact on trading of its common stock (POLA) on Nasdaq. Management believes stockholders’ equity as of March 31, 2026, will be substantially higher based on preliminary internal results, though this is forward-looking.

• ·Subject to procedures under Nasdaq Listing Rule 5810(c)(2)
• ·Common stock continues to trade under symbol POLA with no immediate delisting effect
• ·Does not affect business operations or SEC reporting requirements

07-05-2026

BranchOut Food Inc. received $750,000 in cash proceeds from Kaufman Kapital LLC's full exercise of a warrant for 500,000 shares of common stock at $1.50 per share. Concurrently, the parties amended a $3,400,000 senior secured convertible promissory note by extending its maturity from December 31, 2026, to December 31, 2027, and reducing the interest rate from 12% to 8%; however, the amendment restricts the Company from prepaying more than $2,400,000 of principal prior to September 30, 2027, potentially limiting liquidity flexibility. The Company agreed to file a registration statement within 30 days for resale of the warrant shares and, upon request, for shares issuable from interest conversions.

• ·Warrant originally issued to Kaufman on July 15, 2024
• ·Convertible note originally issued on July 15, 2024
• ·Company to file additional registration statement within 30 days of Kaufman's request for interest conversion shares

07-05-2026

MP Materials reported record Q1 2026 NdPr production of 917 metric tons (+63% YoY) and sales of 1,006 metric tons (+117% YoY), alongside record REO production of 12,983 metric tons (+6% YoY), driving consolidated revenue to $90.6 million (+49% YoY) and Adjusted EBITDA to $36.6 million (from -$2.7 million YoY). Materials segment revenue rose 30% to $72.2 million and Magnetics segment revenue surged 306% to $21.1 million, supported by $42.3 million PPA Income; however, the company recorded a net loss of $8.0 million (improved from $22.6 million but still a loss) and used $1.9 million in operating cash flow. Operational milestones included breaking ground on the 10X magnetics facility.

• ·Net cash used in operating activities: $1.9 million in Q1 2026 (vs. $63.2 million in Q1 2025).
• ·Net cash used in investing activities: $259.8 million in Q1 2026.
• ·Cessation of rare earth concentrate sales to third parties beginning July 2025, resulting in $0 revenue from concentrate in Q1 2026 (vs. $30.1 million in Q1 2025).
• ·Scaled heavy rare earth separation commissioning activities set to begin imminently at Mountain Pass.

07-05-2026

The Joint Corp. reported first quarter 2026 revenues of $14.8 million, up 13% YoY from $13.1 million, with consolidated net income rising 34% to $1.3 million and Adjusted EBITDA increasing 22% to $3.5 million. However, system-wide sales declined 4.9% to $126.1 million, comparable sales fell 4.2%, and total clinic count decreased to 943 from 960 at December 31, 2025. The company repurchased $1.1 million in shares and progressed refranchising efforts, including a $2.3 million agreement to sell 45 clinics to Elite Chiro Group.

• ·Cash flow from operating activities improved to $(1.5) million from $(3.7) million YoY.
• ·Free cash flow improved to $(1.7) million from $(4.0) million YoY.
• ·2026 guidance: System-wide sales $519-552 million; system-wide comp sales -3% to 3%; consolidated Adjusted EBITDA $12.5-13.5 million; new franchised openings 30-35 (net clinic count expected lower than 2025 year-end).
• ·Undrawn $20 million line of credit available through August 2029.
• ·Repurchased rights to three regional developer territories.

07-05-2026

Entergy Corporation entered into forward sale agreements on May 5, 2026, with Wells Fargo Bank, Citibank, N.A., Barclays Bank PLC, and The Bank of Nova Scotia for an aggregate of 19,247,788 shares of common stock at an initial forward sale price of $110.74 per share, with settlement at the company's election on or prior to April 30, 2028. In connection, forward sellers sold these borrowed shares via an underwriting agreement with representatives including Wells Fargo Securities, LLC, granting an option for an additional 2,887,168 shares; the offering closed on May 7, 2026. Physical or net share settlement may result in dilution to earnings per share, while cash settlement could involve payments based on market price versus forward price.

• ·Forward sale price subject to daily adjustments based on overnight bank funding rate less a spread, and decreases on specified dates.
• ·Forward purchasers may accelerate settlement under certain circumstances, including borrowing difficulties, excess dividends, ownership thresholds, extraordinary events, or defaults.

07-05-2026

GigCapital7 entered into Non-Redemption Agreements and a Forward Purchase Agreement dated May 6, 2026, with certain investors (Sellers) for up to a maximum of 546,219 Ordinary Shares in connection with its pending Business Combination with the Company, under which GigCapital7 will domesticate to Delaware and rename to Hadron Energy, Inc. The agreements provide for prepayment from the Trust Account at the redemption price per share, restrict Seller sales below $12.00 per share until maturity six months post-Closing, and include waivers of redemption rights to reduce redemptions ahead of the shareholder vote. No financial settlement amounts are specified beyond share count and per-share pricing, with physical settlement offsetting the prepayment.

• ·Forward Purchase Agreement Maturity Date is six months following Closing Date
• ·Business Combination Agreement originally entered September 27, 2025
• ·Proxy Statement record date: April 15, 2026
• ·GigCapital7 10-K for FY ended December 31, 2025 filed March 6, 2026
• ·Sellers waive redemption rights during term of Forward Purchase Agreement

07-05-2026

On May 1, 2026, Smart Powerr Corp. received a Nasdaq notice for non-compliance with Listing Rule 5550(a)(2), as its common stock closed below $1.00 per share for 30 consecutive trading days, rendering it ineligible for a standard compliance period due to a prior reverse stock split. Trading suspension is set for May 12, 2026, unless the company appeals by May 8, 2026, which it intends to do while exploring further measures like another reverse stock split. No assurance exists that compliance will be regained or listing maintained.

• ·Company ineligible for compliance period under Nasdaq Listing Rule 5810(c)(3)(A)(iv) due to reverse stock split in prior one-year period.
• ·Appeal to Nasdaq Hearings Panel stays suspension pending hearing and any extension.
• ·Trading symbol: CREG; registered on Nasdaq Capital Market.

07-05-2026

At the 2026 Annual Meeting on May 6, Enbridge Inc. shareholders elected all 12 director nominees with strong support ranging from 95.03% (Steven W. Williams) to 99.09% (M.M. Ashar), approved PricewaterhouseCoopers LLP as auditors at 91.89%, say-on-pay advisory vote at 95.58%, and reconfirmed the Shareholder Rights Plan at 95.82%. All proposals passed decisively, though auditor appointment saw the lowest approval at 91.89% with 8.11% withheld. The amended Rights Plan, effective since 1995, next requires approval in 2029 and triggers rights at 20% ownership thresholds to ensure fair treatment in takeovers.

• ·Rights Plan triggers at 20% ownership acquisition without Board approval, allowing other shareholders to buy shares at 50% discount
• ·Rights Plan must next be approved at 2029 annual meeting or it ceases
• ·Original Rights Plan effective November 9, 1995

07-05-2026

JPMorgan Chase & Co. adopted a Certificate of Designations authorizing the issuance of 300,000 shares of 6.100% Fixed-Rate Reset Non-Cumulative Preferred Stock, Series PP, with an aggregate liquidation preference of $3,000,000,000 and $10,000 per share. Dividends are non-cumulative, payable quarterly starting July 1, 2026, at an initial rate of 6.100% per annum, resetting on July 1, 2031 to the 5-year Treasury Rate plus 2.080%. The preferred stock is perpetual, subject to redemption, with standard restrictions on junior dividends and repurchases.

• ·Quarterly dividend payment dates: January 1, April 1, July 1, October 1, beginning July 1, 2026.
• ·Reset Dividend Determination Date: three Business Days prior to each Reset Period.
• ·Reset Periods: every five years starting July 1, 2031.

07-05-2026

On May 7, 2026, Life Time Group Holdings, Inc. consummated the repurchase of 2,192,500 shares of its common stock for an aggregate purchase price of approximately $62,705,000 from certain selling stockholders, including affiliates of Leonard Green & Partners, L.P., TPG Inc., and Partners Group (USA) Inc., pursuant to a Share Repurchase Agreement dated May 5, 2026. The transaction was executed under the Company's stock repurchase program approved by its board of directors in February 2026. No declines or flat metrics reported in this filing.

07-05-2026

Ocugen, Inc. completed a private offering of $115.0 million aggregate principal amount of 6.75% Convertible Senior Notes due 2034, generating net proceeds of approximately $99.5 million after discounts and expenses. The company used $32.7 million of the net proceeds to fully repay the outstanding principal, accrued interest, prepayment fee, and expenses under the Avenue Loan Agreement, terminating that agreement. As-adjusted cash, cash equivalents, and restricted cash as of March 31, 2026, is estimated at $99.0 million for general corporate purposes.

• ·Notes mature on May 15, 2034; interest payable semi-annually starting November 15, 2026.
• ·Conversion not permitted before earliest of May 15, 2027 or reserved share effective date; initially cash settlement only until reserved share effective date.
• ·Company may redeem notes for cash on or after May 15, 2029 if stock price >=130% of conversion price for specified period.
• ·Holders may require repurchase on May 15, 2032 or upon fundamental change.
• ·Events of default include payment defaults, conversion failures, cross-defaults on >$10.0M indebtedness, and bankruptcy events.

07-05-2026

On May 1, 2026, Wellgistics, LLC, a wholly owned subsidiary of Wellgistics Health, Inc. (WGRX), entered into a Forbearance Agreement with Marco Capital, Inc., acknowledging approximately $1.77 million in outstanding obligations under a November 22, 2024 loan agreement. Marco Capital agreed to forbear from exercising remedies until June 15, 2026, in exchange for bi-weekly payments of $50,000 starting May 5, 2026, and potential repayment from future financing proceeds. The obligations now accrue interest at Term SOFR plus 11.5% per annum from May 5, 2026.

• ·Original loan dated November 22, 2024
• ·Forbearance period ends June 15, 2026
• ·Filing date: May 7, 2026

07-05-2026

Fox Factory Holding Corp. reported first quarter fiscal 2026 net sales of $368.7 million, up 3.9% YoY to the high end of guidance, with Powered Vehicles Group (PVG) sales rising 17.4% to $143.4 million, Aftermarket Applications Group (AAG) up 2.6% to $114.8 million, but Specialty Sports Group (SSG) declining 8.7% to $110.5 million. Adjusted EBITDA of $35.7 million exceeded guidance but declined from $39.6 million YoY with margin contracting to 9.7% from 11.2%, while gross margin fell to 28.9% from 30.9%; net loss was $15.0 million versus $259.7 million prior year (impacted by goodwill impairment). The company completed divestiture of Phoenix AAG operations (Shock Therapy, Upfit UTV, Geiser) with proceeds for debt reduction and reaffirmed $50 million fiscal 2026 cost savings.

• ·Q2 FY2026 guidance: Net sales $343M-$365M; Adjusted EBITDA $32M-$40M.
• ·FY2026 guidance reaffirmed: Net sales $1.328B-$1.416B; Adjusted EBITDA $174M-$203M.
• ·Total operating expenses $100.4M (27.2% of sales) vs. $360.3M (101.5%) prior year.
• ·Total debt increased to $688.2M from $673.5M QoQ.
• ·Credit agreement amended in May to expand net leverage covenant to 5.0x from 4.5x.

07-05-2026

ARTIVION, INC. filed a Form 8-K on 2026-05-07 under Accession No. 0001628280-26-032097, reporting entry into a material definitive agreement (Item 1.01) and results of operations and financial condition (Item 2.02), with financial statements and exhibits provided (Item 9.01). This is a multi-item filing with no specific transaction details, dollar values, financial metrics, or period-over-period comparisons disclosed in the provided information. No positive or negative performance indicators are available.

07-05-2026

Kodiak AI reported Q1 2026 revenue of $1.8 million, up 74% quarter-over-quarter, with strong operational scaling including 28 Customer-Owned Driverless Vehicles (40% QoQ growth) and over 23,500 cumulative hours of paid driverless operations (120% increase QoQ). The company announced a $100 million PIPE financing to bolster liquidity, which ended Q1 at $90.2 million in cash and marketable securities. However, Q1 net cash used in operating activities was $29.5 million and Free Cash Flow was negative $35.0 million, reflecting high cash burn amid growth investments.

• ·Announced conferences: Bank of America Industrials Conference on May 12, 2026; J.P. Morgan Global Technology, Media, and Communications Conference on May 19, 2026; TD Cowen 54th Annual Technology, Media & Telecom Conference on May 27, 2026.
• ·Property and equipment, net increased to $29.746 million at Q1 end from $26.553 million at Q4 end.
• ·Long-haul driverless launch targeted for late 2026.

07-05-2026

GeoVax Labs, Inc. (Nasdaq: GOVX) entered into a warrant inducement agreement with existing institutional investors for the immediate exercise of existing warrants to purchase 501,144 shares of common stock, generating gross cash proceeds of approximately $595,000 before fees, to be used for working capital and general corporate purposes. In exchange, investors will receive new unregistered warrants to purchase up to 1,002,288 shares at an exercise price of $1.65, exercisable after shareholder approval and expiring five years thereafter. The transaction closing is expected on or about May 8, 2026.

• ·New warrants initially exercisable upon shareholder approval (Approval Date) and expire 5 years following Approval Date.
• ·Private placement relies on Section 4(a)(2) of Securities Act and Regulation D exemption.
• ·GEO-MVA advancing to pivotal Phase 3 trial in second half of 2026.
• ·Gedeptin completed multicenter Phase 1/2 trial in advanced head and neck cancer.

07-05-2026

BuzzFeed, Inc. and its subsidiaries entered into Amendment No. 4 to their Credit Agreement on May 7, 2026, amending terms of the original May 23, 2025 agreement and prior amendments. The amendment includes a limited waiver of specified defaults, notably the failure to repay $5,000,000 in loans by April 30, 2026, missing milestones from Amendment No. 3, and late milestone fee payments, providing temporary relief amid financial covenant breaches. No performance improvements or new funding were disclosed.

• ·Prior amendments to Credit Agreement: Amendment No. 1 (July 31, 2025), No. 2 (August 25, 2025), No. 3 (March 11, 2026).
• ·Waiver is limited solely to specified defaults and does not modify other terms or imply consent to future issues.
• ·Effectiveness requires payment of fees under Amendment No. 4 Fee Letter and confirmation of no other Events of Default post-amendment.

07-05-2026

Mercer International Inc.'s German subsidiaries entered into a Waiver and Consent effective May 4, 2026, on their €370.1 million revolving credit facility, waiving the Leverage Ratio covenant (max 3.50:1.00) for the first three fiscal quarters of FY2026, providing temporary covenant relief. However, the waiver imposes significant restrictions including a €300 million utilization cap if leverage exceeds 2.00:1.00, US$30 million average liquidity requirement, €60 million FY2026 capex limit, restricted distributions until September 30, 2026 (max €15 million conditionally), additional security grants over assets worth at least 110% of utilized amounts, enhanced reporting, and higher interest margins of 2.50%-4.25%. New events of default include non-compliance, director terminations, cross-defaults to senior notes or other facilities, and North American bankruptcy proceedings.

• ·Original Credit Agreement dated September 15, 2022, amended and restated March 22, 2023
• ·Security includes trade receivables, finished goods inventory, bank accounts, intra-group loans, and share pledges
• ·Cross-default to Company's Canadian revolving credit facility and senior notes indentures
• ·Reporting requirements include business affairs, financial info, 13-week liquidity forecasts, and 12-month resource sufficiency confirmations

07-05-2026

Healthcare Realty Holdings, L.P. (a subsidiary of Healthcare Realty Trust Incorporated) entered into a base capped call option transaction (with potential additional transaction) with an unnamed Dealer as a hedge for the issuance of $600,000,000 aggregate initial principal amount of 3.00% Exchangeable Senior Notes due 2032 (upsized by up to $100,000,000 pursuant to initial purchasers' option). The transaction references HR Class A common stock with a Strike Price of $23.0065, Cap Price of $27.4120, and Option Entitlement based on an initial conversion rate factor of 43.4660. The notes are governed by an Indenture dated May 7, 2026, with U.S. Bank Trust Company, N.A. as trustee, following a Purchase Agreement dated May 4, 2026.

• ·Trade Date: May [ ], 2026
• ·Effective Date: Closing date of initial issuance of Exchangeable Notes
• ·Free Exchangeability Deadline: October 15, 2031
• ·Expiration Date: January 15, 2032
• ·Offering Memorandum dated May 4, 2026
• ·Purchase Agreement dated May 4, 2026
• ·Indenture dated May 7, 2026

07-05-2026

Ingram Micro Holding Corporation announced the launch of a $330 million secondary offering of its common stock by Ingram Holdco, LLC, an affiliate of Platinum Equity, LLC, with the selling stockholder to receive all proceeds and an underwriter option for an additional $45 million. Concurrently, the company plans a $30 million share repurchase from underwriters at the offering price, funded by cash on hand as part of its $175 million program (leaving $70 million capacity), signaling confidence despite not receiving offering proceeds. The transactions are expected to close together, though the offering does not depend on the repurchase.

• ·Underwriter representatives: Morgan Stanley & Co. LLC, Goldman Sachs & Co. LLC, J.P. Morgan Securities LLC.
• ·Offering pursuant to effective automatic shelf registration on Form S-3.
• ·Share repurchase conditioned on offering closing; offering closing not conditioned on repurchase.
• ·Announcement date: May 5, 2026; SEC filing date: May 7, 2026.

07-05-2026

American Tower Corp /MA/ filed an 8-K on May 7, 2026 (AccNo: 0001053507-26-000108), reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement. No specific details on the nature, parties, terms, or financial impact of the agreement or obligation are disclosed in the provided filing summary. No quantitative metrics, comparisons, or further context provided.

07-05-2026

Apollo Debt Solutions BDC filed an 8-K on 2026-05-07 disclosing under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement, with financial statements and exhibits provided under Item 9.01. No specific transaction details, dollar values, or financial impacts are disclosed in the provided filing summary. This is a multi-item mandatory disclosure with no quantitative metrics or period-over-period comparisons mentioned.

07-05-2026

New Fortress Energy Inc. filed an 8-K on 2026-05-07 disclosing under Item 3.01 a notice of delisting or failure to satisfy a continued listing rule or standard, or transfer of listing, which is a material negative event. Item 9.01 reports financial statements and exhibits. No financial metrics, transaction values, or other quantitative details are disclosed.

07-05-2026

Liberty Energy Inc. filed a Form 8-K on 2026-05-07 (AccNo: 0001694028-26-000027, size: 156 KB) reporting under Item 1.01 the entry into a Material Definitive Agreement. No details on the nature of the agreement, parties involved, dollar value, strategic importance, financial impacts, or any positive/negative metrics are disclosed in the provided information. Sector is not specified.

• ·Filing Accession Number: 0001694028-26-000027
• ·Filing size: 156 KB

07-05-2026

Automatic Data Processing, Inc. executed an Underwriting Agreement on May 4, 2026, with BNP Paribas Securities Corp., BofA Securities, Inc., and J.P. Morgan Securities LLC as representatives of the underwriters to issue and sell $1,000,000,000 aggregate principal amount of 5.000% senior notes due 2036. The notes were issued on May 7, 2026, under an indenture with U.S. Bank Trust Company, National Association as trustee, registered on Form S-3 (File No. 333-281920). A legal opinion on the notes' legality was provided by Davis Polk & Wardwell LLP.

• ·Underwriting Agreement dated May 4, 2026 (Exhibit 1.1)
• ·Fifth Supplemental Indenture (Exhibit 4.1)
• ·Prospectus supplement dated May 4, 2026; base prospectus dated September 4, 2024
• ·Registration Statement on Form S-3 (File No. 333-281920)

07-05-2026

On May 7, 2026, Trinity Capital Inc. entered into open market sale agreements with Jefferies LLC, B. Riley Securities, Inc., Keefe, Bruyette & Woods, Inc., and Compass Point Research & Trading, LLC to issue and sell up to $300,000,000 in aggregate offering price of its common stock, par value $0.001 per share, through an at-the-market offering. The company intends to use substantially all net proceeds for investments aligning with its objective and strategy, and general corporate purposes. Sales agents will receive commissions up to 2.00% of the gross sales price.

• ·Sales Agreements filed as Exhibits 10.1 to 10.4
• ·Prospectus supplement dated May 7, 2026, accompanying prospectus dated August 11, 2025
• ·Offered pursuant to automatic shelf registration statement on Form N-2 (File No. 333-289495)
• ·Securities registered: Common Stock (TRIN), 7.875% Notes Due 2029 (TRINZ, TRINI) on Nasdaq Global Select Market

07-05-2026

JERSEY CENTRAL POWER & LIGHT CO filed an 8-K on 2026-05-07 disclosing under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. Item 9.01 includes financial statements and exhibits. No transaction details, dollar values, financial impacts, or performance metrics are disclosed.

07-05-2026

Structure Therapeutics Inc. filed a Form 8-K on 2026-05-07 reporting under Item 1.01 entry into a material definitive agreement, under Item 2.02 results of operations and financial condition, under Item 8.01 other events, and under Item 9.01 financial statements and exhibits. This is a multi-item mandatory filing with AccNo 0001104659-26-057226 and size 787 KB. No specific transaction details, financial metrics, dollar values, percentages, or period-over-period comparisons are disclosed in the provided filing summary.

07-05-2026

BT Brands, Inc. (Nasdaq: BTBD, BTBDW) terminated its Agreement and Plan of Merger with Aero Velocity Inc. upon expiration of the contractual term, as the SEC registration statement was not declared effective by the April 30, 2026 deadline. The company stated that termination is in the best interests of shareholders, with no ongoing agreement or arrangement with Aero, and will focus on improving restaurant profitability, strengthening cash flow, maintaining balance sheet flexibility, and evaluating other opportunities to enhance shareholder value.

• ·Termination effected in accordance with merger agreement terms
• ·Filed Current Report on Form 8-K with SEC on May 7, 2026

07-05-2026

Pathfinder Bancorp, Inc. entered into the Fourth Amendment to its Registration Rights Agreement with Castle Creek Capital Partners VII, L.P. on May 4, 2026, extending the deadline for filing a resale registration statement from May 8, 2026, to May 8, 2027. This follows prior amendments beginning in 2023 and relates to a 2019 private placement of securities.

• ·Original Securities Purchase Agreement and Registration Rights Agreement both dated May 8, 2019.
• ·Amendments to Registration Rights Agreement occurred beginning in 2023, with annual extensions for three prior years.

07-05-2026

Renasant Corporation announced the pricing of a $300 million public offering of 6.25% Fixed-to-Floating Rate Subordinated Notes due 2036, qualifying as Tier 2 capital, with proceeds intended for general corporate purposes including potential redemption of $40 million of outstanding 5.50% notes due 2031. The offering is expected to close on May 7, 2026. The company, with approximately $27.1 billion in assets and 282 offices, disclosed ongoing risks including a material weakness in internal controls identified in its recent 10-K.

• ·Notes bear fixed 6.25% interest semi-annually from May 7, 2026 to June 1, 2031, then floating Three-Month Term SOFR + 245 bps quarterly.
• ·Redeemable on or after June 1, 2031 at 100% principal plus accrued interest.
• ·Keefe, Bruyette & Woods as lead book-running manager; Stephens Inc. as active book-running manager; Park Place Capital Securities, Piper Sandler, Raymond James as co-managers.
• ·Registration Statement on Form S-3 (File No. 333-284828).

07-05-2026

HWH International Inc. entered a binding term sheet dated May 5, 2026, for a $10M PIPE investment from Smart Dynamics Technology Limited (wholly owned by Value Crepuscular Limited), issuing 20M common shares at $0.50 per share and 160M warrants exercisable at $0.63 (potential $100.8M proceeds if fully exercised). Concurrently, HWH will issue 2M bonus shares to management and employees as non-cash compensation, subject to a 12-month lock-up. The deal grants the investor board appointment rights for three directors, anti-dilution protections for two years, and registration rights, but involves significant dilution for existing shareholders and a potential shift in control, subject to board, shareholder, and Nasdaq approvals.

• ·Warrants expire 48 months from issuance and are exercisable anytime prior
• ·Investor anti-dilution period: 2 years if holding majority of common stock post-closing
• ·Registration statement to be filed within 60 days of closing, effective within 90 days of filing
• ·Term sheet expires in 3 months unless definitive agreement executed
• ·Investor right to appoint 3 board directors persists until ceases to own majority of common stock

07-05-2026

Alset Inc. and HWH International Inc. executed a Termination Agreement dated May 6, 2026, mutually terminating prior Term Sheet, Stock Purchase Agreement, and Convertible Promissory Note related to the contemplated sale and purchase of shares in Hapi Metaverse Inc. The agreements are of no further force or effect after the Termination Date, with each party representing full authority to enter the termination and bearing its own costs and expenses. No further obligations exist under the prior agreements.

• ·Termination effective as of May 6, 2026
• ·Governed by laws of the State of Delaware
• ·May be executed in counterparts, including electronically

07-05-2026

On May 7, 2026, Alector, Inc. entered into a Sales Agreement with TD Securities (USA) LLC (TD Cowen) to offer and sell up to $125,000,000 of its common stock through at-the-market offerings on Nasdaq. TD Cowen will receive compensation of up to 3.0% of the gross sales price, with sales parameters set by the Company and no obligation to sell any shares. Net proceeds, if any, will support general corporate purposes including research, development, manufacturing, working capital, and potential acquisitions.

• ·Sales Agreement supported by shelf registration on Form S-3 (File No. 333-294241), effective April 30, 2026.
• ·Prospectus supplement filed with SEC on May 7, 2026.
• ·Either party may terminate the agreement upon 10 days' written notice, or immediately by TD Cowen upon Material Adverse Change.
• ·No agreements or commitments for specific acquisitions or strategic transactions at this time.

07-05-2026

Viasat, Inc. (NASDAQ: VSAT) appointed Shekar Ayyar, Chairman and CEO of Arrcus, Inc., and Jinhy Yoon, former EVP at PIMCO, to its Board of Directors and Strategic Review Committee, effective immediately, bringing the board to 10 members with 8 independents. The company also entered into a cooperation agreement with Carronade Capital Management, LP, which includes customary standstill and voting provisions. This move follows constructive dialogue and aims to support the ongoing strategic review, execution of the ViaSat-3 constellation service entry, and value unlocking across Viasat's businesses including Defense and Advanced Technologies.

• ·Carronade Capital founded in 2019, launched July 1, 2020.
• ·Viasat completed acquisition of Inmarsat in May 2023.
• ·Jinhy Yoon previously served on Intelsat S.A. Board, guiding its sale to SES S.A. in July 2025.
• ·Full cooperation agreement to be filed as exhibit to Form 8-K.

07-05-2026

Oncor reported Q1 2026 net income of $212 million, up 17% YoY from $181 million, with operating revenues increasing 11% to $1,724 million driven by UTM, SRP, updated rates, and customer growth; however, results were partially offset by lower customer consumption from milder weather, higher operation and maintenance expense (up 9% to $403 million), depreciation (up 14% to $328 million), and interest expense (up 23% to $227 million). The PUCT approved a $560 million (8.7%) revenue increase effective June 2026, and Oncor's 2026 capex budget is $9.0 billion, up 25% from 2025 actuals, supporting operational growth including 13,400 new premises and 19% higher transmission POI requests.

• ·Moody’s revised Oncor’s credit ratings outlook from negative to stable.
• ·As of Mar 31, 2026, active generation POI queue: 47% storage, 40% solar, 8% wind, 5% gas.
• ·Active LC&I queue includes 271 GW from data centers and over 18 GW from other industrial sectors.
• ·Oncor submitted 122 GW large load and 5.2 GW medium load forecasts through 2036 for ERCOT 2026 RTP.
• ·ERCOT endorsed ~4 GW transmission upgrades for south DFW region (in-service 2026-2032).
• ·Available liquidity $3.3B as of May 6, 2026.
• ·Q1 2026 cash from operating activities $537M vs $194M in Q1 2025.

07-05-2026

DarkPulse, Inc. (OTCQB: DPLS) announced the execution of an exclusive patent license agreement (NLICENSE-NAWCWDCL-26-027) with the Naval Air Warfare Center Weapons Division (NAWCWD) of the U.S. Department of the Navy, granting exclusive U.S. rights to commercialize three key patents on advanced LADAR laser targeting technologies (U.S. Patent Nos. 10,031,215 B1; 7,312,855 B1; 7,948,610 B2). As part of its commercialization plan, DarkPulse will deliver a working prototype of the laser targeting system to its manufacturing partner for full-scale production, with all products manufactured substantially in the United States. CEO Dennis O’Leary described the technologies as a transformative addition to the company's laser sensing portfolio for defense, security, and industrial applications.

• ·License agreement number: NLICENSE-NAWCWDCL-26-027
• ·Patent issuance dates: July 24, 2018 (10,031,215 B1); December 25, 2007 (7,312,855 B1); May 24, 2011 (7,948,610 B2)
• ·All products for U.S. use or sale must be manufactured substantially in the United States
• ·U.S. government retains non-exclusive, irrevocable, royalty-free license for its own use

07-05-2026

American Honda Receivables LLC and American Honda Finance Corporation entered into an Underwriting Agreement on May 5, 2026, with Barclays Capital Inc., Mizuho Securities USA LLC, SMBC Nikko Securities America, Inc., and SG Americas Securities, LLC for the issuance of $2,105,270,000 in asset-backed notes (Classes A-1 at 3.828%, A-2a at 4.11%, A-2b at SOFR + 0.38%, A-3 at 4.30%, A-4 at 4.33%) by Honda Auto Receivables 2026-2 Owner Trust, with closing on or about May 13, 2026. The notes are backed by receivables from retail installment contracts for new and used Honda or Acura automobiles, and AHFC will retain at least 5% of each class. Several related agreements, including Receivables Purchase Agreement, Sale and Servicing Agreement, and Indenture, will be executed on the Closing Date.

• ·Trust established pursuant to Trust Agreement dated April 6, 2026, to be amended and restated as of Closing Date
• ·Receivables consist of retail installment sale contracts or installment loan contracts relating to new or used Honda or Acura automobiles

07-05-2026

GM Financial Automobile Leasing Trust 2026-2 entered into an Administration Agreement dated April 1, 2026, with GM Financial (as Administrator), GMF Leasing LLC (as Depositor), and Computershare Trust Company, N.A. (as Indenture Trustee). The agreement delegates the performance of the Issuer's and Owner Trustee's duties under related documents, including the Indenture and Trust Agreement, such as preparing reports, filings, notices, and ensuring compliance. No financial metrics, changes, or performance data are disclosed in the filing.